APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Cancer Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Kidney Cancer Treatment Drugs Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchKidney Cancer Treatment Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Cancer Treatment Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Kidney Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Cancer Treatment Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Cancer Treatment Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Kidney Cancer Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Kidney Cancer Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Kidney Cancer Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Kidney Cancer Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Kidney Cancer Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Kidney Cancer Treatment Drugs include Eisai, Novartis, Merck, Roche, Pfizer, Bayer, AstraZeneca, Prometheus Labs and Incyte, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Kidney Cancer Treatment Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Kidney Cancer Treatment Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Kidney Cancer Treatment Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney Cancer Treatment Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Kidney Cancer Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Kidney Cancer Treatment Drugs sales, projected growth trends, production technology, application and end-user industry.

Kidney Cancer Treatment Drugs Segment by Company

Eisai

Novartis

Merck

Roche

Pfizer

Bayer

AstraZeneca

Prometheus Labs

Incyte

Exelixis

Bristol-Myers Squibb

Aveo Pharmaceuticals

Argos Therapeutics

Amgen/Allergan

Kidney Cancer Treatment Drugs Segment by Type

Angiogenesis Inhibitors

Cytokine Immunotherapy (IL-2)

Monoclonal Antibodies

mTOR Inhibitors

Kidney Cancer Treatment Drugs Segment by Application

Research Institutes

Hospitals

Diagnostic Centers

Others

Kidney Cancer Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Cancer Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Cancer Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Cancer Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Kidney Cancer Treatment Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Kidney Cancer Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Cancer Treatment Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Angiogenesis Inhibitors Major Manufacturers Table 3. Cytokine Immunotherapy (IL-2) Major Manufacturers Table 4. Monoclonal Antibodies Major Manufacturers Table 5. mTOR Inhibitors Major Manufacturers Table 6. Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Research Institutes Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. Diagnostic Centers Major Manufacturers Table 10. Others Major Manufacturers Table 11. Kidney Cancer Treatment Drugs Industry Trends Table 12. Kidney Cancer Treatment Drugs Industry Drivers Table 13. Kidney Cancer Treatment Drugs Industry Opportunities and Challenges Table 14. Kidney Cancer Treatment Drugs Industry Restraints Table 15. Global Kidney Cancer Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Kidney Cancer Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Kidney Cancer Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2021-2026) Table 19. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2027-2032) Table 20. Global Kidney Cancer Treatment Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Kidney Cancer Treatment Drugs Sales by Region (2021-2026) & (K Units) Table 22. Global Kidney Cancer Treatment Drugs Sales by Region (2027-2032) & (K Units) Table 23. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2021-2026) Table 24. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2027-2032) Table 25. Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Kidney Cancer Treatment Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Kidney Cancer Treatment Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global Kidney Cancer Treatment Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Kidney Cancer Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Kidney Cancer Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Kidney Cancer Treatment Drugs Manufacturers, Product Type & Application Table 33. Global Kidney Cancer Treatment Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Kidney Cancer Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Kidney Cancer Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2021-2026) Table 40. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2027-2032) Table 41. Global Kidney Cancer Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 43. Global Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 44. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2021-2026) Table 45. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2027-2032) Table 46. Global Kidney Cancer Treatment Drugs Price by Type (2021-2026) & (US$/Unit) Table 47. Global Kidney Cancer Treatment Drugs Price by Type (2027-2032) & (US$/Unit) Table 48. Global Kidney Cancer Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2021-2026) Table 52. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2027-2032) Table 53. Global Kidney Cancer Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 56. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2021-2026) Table 57. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2027-2032) Table 58. Global Kidney Cancer Treatment Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Kidney Cancer Treatment Drugs Price by Application (2027-2032) & (US$/Unit) Table 60. Eisai Company Information Table 61. Eisai Business Overview Table 62. Eisai Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Eisai Kidney Cancer Treatment Drugs Product Portfolio Table 64. Eisai Recent Development Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis Kidney Cancer Treatment Drugs Product Portfolio Table 69. Novartis Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Merck Kidney Cancer Treatment Drugs Product Portfolio Table 74. Merck Recent Development Table 75. Roche Company Information Table 76. Roche Business Overview Table 77. Roche Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Roche Kidney Cancer Treatment Drugs Product Portfolio Table 79. Roche Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Pfizer Kidney Cancer Treatment Drugs Product Portfolio Table 84. Pfizer Recent Development Table 85. Bayer Company Information Table 86. Bayer Business Overview Table 87. Bayer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Bayer Kidney Cancer Treatment Drugs Product Portfolio Table 89. Bayer Recent Development Table 90. AstraZeneca Company Information Table 91. AstraZeneca Business Overview Table 92. AstraZeneca Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. AstraZeneca Kidney Cancer Treatment Drugs Product Portfolio Table 94. AstraZeneca Recent Development Table 95. Prometheus Labs Company Information Table 96. Prometheus Labs Business Overview Table 97. Prometheus Labs Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Prometheus Labs Kidney Cancer Treatment Drugs Product Portfolio Table 99. Prometheus Labs Recent Development Table 100. Incyte Company Information Table 101. Incyte Business Overview Table 102. Incyte Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Incyte Kidney Cancer Treatment Drugs Product Portfolio Table 104. Incyte Recent Development Table 105. Exelixis Company Information Table 106. Exelixis Business Overview Table 107. Exelixis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Exelixis Kidney Cancer Treatment Drugs Product Portfolio Table 109. Exelixis Recent Development Table 110. Bristol-Myers Squibb Company Information Table 111. Bristol-Myers Squibb Business Overview Table 112. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Portfolio Table 114. Bristol-Myers Squibb Recent Development Table 115. Aveo Pharmaceuticals Company Information Table 116. Aveo Pharmaceuticals Business Overview Table 117. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Portfolio Table 119. Aveo Pharmaceuticals Recent Development Table 120. Argos Therapeutics Company Information Table 121. Argos Therapeutics Business Overview Table 122. Argos Therapeutics Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Argos Therapeutics Kidney Cancer Treatment Drugs Product Portfolio Table 124. Argos Therapeutics Recent Development Table 125. Amgen/Allergan Company Information Table 126. Amgen/Allergan Business Overview Table 127. Amgen/Allergan Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Amgen/Allergan Kidney Cancer Treatment Drugs Product Portfolio Table 129. Amgen/Allergan Recent Development Table 130. North America Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 133. North America Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 134. North America Kidney Cancer Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 135. North America Kidney Cancer Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 136. North America Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 139. North America Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 140. North America Kidney Cancer Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 141. North America Kidney Cancer Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 142. North America Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. North America Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. North America Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. North America Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 147. North America Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 148. North America Kidney Cancer Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 149. North America Kidney Cancer Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 150. United States Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 151. Canada Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 152. Europe Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 155. Europe Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 156. Europe Kidney Cancer Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Europe Kidney Cancer Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Europe Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 161. Europe Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 162. Europe Kidney Cancer Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Europe Kidney Cancer Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Europe Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Europe Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 169. Europe Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 170. Europe Kidney Cancer Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Europe Kidney Cancer Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Germany Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 173. France Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 174. U.K. Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 175. Italy Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 176. Netherlands Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 177. China Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 178. China Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 179. China Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 180. China Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 181. China Kidney Cancer Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 182. China Kidney Cancer Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 183. China Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 184. China Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 185. China Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 186. China Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 187. China Kidney Cancer Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 188. China Kidney Cancer Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 189. Asia Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 190. Asia Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 191. Asia Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 192. Asia Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 193. Asia Kidney Cancer Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 194. Asia Kidney Cancer Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 195. Asia Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 196. Asia Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 197. Asia Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 198. Asia Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 199. Asia Kidney Cancer Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 200. Asia Kidney Cancer Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 201. Asia Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Asia Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Asia Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Asia Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. Asia Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 206. Asia Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 207. Asia Kidney Cancer Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 208. Asia Kidney Cancer Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 209. Japan Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 210. South Korea Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 211. India Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 212. Australia Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 213. China Taiwan Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 214. Southeast Asia Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 215. SAMEA Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 218. SAMEA Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 219. SAMEA Kidney Cancer Treatment Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 220. SAMEA Kidney Cancer Treatment Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 221. SAMEA Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 222. SAMEA Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 223. SAMEA Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 224. SAMEA Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 225. SAMEA Kidney Cancer Treatment Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 226. SAMEA Kidney Cancer Treatment Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 227. SAMEA Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. SAMEA Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. SAMEA Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. SAMEA Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 231. SAMEA Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 232. SAMEA Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 233. SAMEA Kidney Cancer Treatment Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 234. SAMEA Kidney Cancer Treatment Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 235. Brazil Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 236. Argentina Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 237. Chile Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 238. Colombia Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 239. Peru Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 240. Saudi Arabia Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 241. Israel Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 242. UAE Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 243. Turkey Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 244. Iran Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 245. Egypt Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Kidney Cancer Treatment Drugs Distributors List Table 249. Kidney Cancer Treatment Drugs Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Kidney Cancer Treatment Drugs Image Figure 2. Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Cancer Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Angiogenesis Inhibitors Image Figure 5. Cytokine Immunotherapy (IL-2) Image Figure 6. Monoclonal Antibodies Image Figure 7. mTOR Inhibitors Image Figure 8. Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Kidney Cancer Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Research Institutes Image Figure 11. Hospitals Image Figure 12. Diagnostic Centers Image Figure 13. Others Image Figure 14. Global Kidney Cancer Treatment Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global Kidney Cancer Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global Kidney Cancer Treatment Drugs Sales (2021-2032) & (K Units) Figure 20. Global Kidney Cancer Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Kidney Cancer Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Europe Kidney Cancer Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 24. China Kidney Cancer Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Kidney Cancer Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Global Kidney Cancer Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Kidney Cancer Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Kidney Cancer Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global Kidney Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Kidney Cancer Treatment Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2021-2032) Figure 36. Global Kidney Cancer Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global Kidney Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Kidney Cancer Treatment Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2021-2032) Figure 42. North America Kidney Cancer Treatment Drugs Revenue Share by Type (2021-2032) Figure 43. North America Kidney Cancer Treatment Drugs Sales Share by Type (2021-2032) Figure 44. North America Kidney Cancer Treatment Drugs Revenue Share by Application (2021-2032) Figure 45. North America Kidney Cancer Treatment Drugs Sales Share by Application (2021-2032) Figure 46. North America Kidney Cancer Treatment Drugs Revenue Share by Country (2021-2032) Figure 47. North America Kidney Cancer Treatment Drugs Sales Share by Country (2021-2032) Figure 48. Europe Kidney Cancer Treatment Drugs Revenue Share by Type (2021-2032) Figure 49. Europe Kidney Cancer Treatment Drugs Sales Share by Type (2021-2032) Figure 50. Europe Kidney Cancer Treatment Drugs Revenue Share by Application (2021-2032) Figure 51. Europe Kidney Cancer Treatment Drugs Sales Share by Application (2021-2032) Figure 52. Europe Kidney Cancer Treatment Drugs Revenue Share by Country (2021-2032) Figure 53. Europe Kidney Cancer Treatment Drugs Sales Share by Country (2021-2032) Figure 54. China Kidney Cancer Treatment Drugs Revenue Share by Type (2021-2032) Figure 55. China Kidney Cancer Treatment Drugs Sales Share by Type (2021-2032) Figure 56. China Kidney Cancer Treatment Drugs Revenue Share by Application (2021-2032) Figure 57. China Kidney Cancer Treatment Drugs Sales Share by Application (2021-2032) Figure 58. Asia Kidney Cancer Treatment Drugs Revenue Share by Type (2021-2032) Figure 59. Asia Kidney Cancer Treatment Drugs Sales Share by Type (2021-2032) Figure 60. Asia Kidney Cancer Treatment Drugs Revenue Share by Application (2021-2032) Figure 61. Asia Kidney Cancer Treatment Drugs Sales Share by Application (2021-2032) Figure 62. Asia Kidney Cancer Treatment Drugs Revenue Share by Country (2021-2032) Figure 63. Asia Kidney Cancer Treatment Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA Kidney Cancer Treatment Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA Kidney Cancer Treatment Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA Kidney Cancer Treatment Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA Kidney Cancer Treatment Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA Kidney Cancer Treatment Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA Kidney Cancer Treatment Drugs Sales Share by Country (2021-2032) Figure 70. Kidney Cancer Treatment Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Kidney Cancer Treatment Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Angiogenesis Inhibitors
  • Cytokine Immunotherapy (IL-2)
  • Monoclonal Antibodies
  • mTOR Inhibitors
Applications
  • Research Institutes
  • Hospitals
  • Diagnostic Centers
  • Others
Companies covered
  • Eisai
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • Bayer
  • AstraZeneca
  • Prometheus Labs
  • Incyte
  • Exelixis
  • Bristol-Myers Squibb
  • Aveo Pharmaceuticals
  • Argos Therapeutics
  • Amgen/Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Kidney Cancer Treatment Drugs Market by Type
  3. 1.2.1 Global Kidney Cancer Treatment Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Angiogenesis Inhibitors
  5. 1.2.3 Cytokine Immunotherapy (IL-2)
  6. 1.2.4 Monoclonal Antibodies
  7. 1.2.5 mTOR Inhibitors
  8. 1.3 Kidney Cancer Treatment Drugs Market by Application
  9. 1.3.1 Global Kidney Cancer Treatment Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Research Institutes
  11. 1.3.3 Hospitals
  12. 1.3.4 Diagnostic Centers
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Kidney Cancer Treatment Drugs Market Dynamics
  1. 2.1 Kidney Cancer Treatment Drugs Industry Trends
  2. 2.2 Kidney Cancer Treatment Drugs Industry Drivers
  3. 2.3 Kidney Cancer Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Kidney Cancer Treatment Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Kidney Cancer Treatment Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Kidney Cancer Treatment Drugs Revenue by Region
  3. 3.2.1 Global Kidney Cancer Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Kidney Cancer Treatment Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Kidney Cancer Treatment Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Kidney Cancer Treatment Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Kidney Cancer Treatment Drugs Sales by Region
  9. 3.4.1 Global Kidney Cancer Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Kidney Cancer Treatment Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Kidney Cancer Treatment Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Kidney Cancer Treatment Drugs Revenue by Manufacturers
  2. 4.1.1 Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Kidney Cancer Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Kidney Cancer Treatment Drugs Sales by Manufacturers
  6. 4.2.1 Global Kidney Cancer Treatment Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Kidney Cancer Treatment Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Kidney Cancer Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Kidney Cancer Treatment Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Kidney Cancer Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Kidney Cancer Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Kidney Cancer Treatment Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Kidney Cancer Treatment Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Kidney Cancer Treatment Drugs Market CR5 and HHI
  16. 4.8.2 2025 Kidney Cancer Treatment Drugs Tier 1, Tier 2, and Tier 3
5 Kidney Cancer Treatment Drugs Market by Type
  1. 5.1 Global Kidney Cancer Treatment Drugs Revenue by Type
  2. 5.1.1 Global Kidney Cancer Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Kidney Cancer Treatment Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Kidney Cancer Treatment Drugs Sales by Type
  6. 5.2.1 Global Kidney Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Kidney Cancer Treatment Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Kidney Cancer Treatment Drugs Price by Type
6 Kidney Cancer Treatment Drugs Market by Application
  1. 6.1 Global Kidney Cancer Treatment Drugs Revenue by Application
  2. 6.1.1 Global Kidney Cancer Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Kidney Cancer Treatment Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Kidney Cancer Treatment Drugs Sales by Application
  6. 6.2.1 Global Kidney Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Kidney Cancer Treatment Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Kidney Cancer Treatment Drugs Price by Application
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Kidney Cancer Treatment Drugs Product Portfolio
  6. 7.1.5 Eisai Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Kidney Cancer Treatment Drugs Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Kidney Cancer Treatment Drugs Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Kidney Cancer Treatment Drugs Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Kidney Cancer Treatment Drugs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Kidney Cancer Treatment Drugs Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 AstraZeneca
  38. 7.7.1 AstraZeneca Company Information
  39. 7.7.2 AstraZeneca Business Overview
  40. 7.7.3 AstraZeneca Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AstraZeneca Kidney Cancer Treatment Drugs Product Portfolio
  42. 7.7.5 AstraZeneca Recent Developments
  43. 7.8 Prometheus Labs
  44. 7.8.1 Prometheus Labs Company Information
  45. 7.8.2 Prometheus Labs Business Overview
  46. 7.8.3 Prometheus Labs Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Prometheus Labs Kidney Cancer Treatment Drugs Product Portfolio
  48. 7.8.5 Prometheus Labs Recent Developments
  49. 7.9 Incyte
  50. 7.9.1 Incyte Company Information
  51. 7.9.2 Incyte Business Overview
  52. 7.9.3 Incyte Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Incyte Kidney Cancer Treatment Drugs Product Portfolio
  54. 7.9.5 Incyte Recent Developments
  55. 7.10 Exelixis
  56. 7.10.1 Exelixis Company Information
  57. 7.10.2 Exelixis Business Overview
  58. 7.10.3 Exelixis Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Exelixis Kidney Cancer Treatment Drugs Product Portfolio
  60. 7.10.5 Exelixis Recent Developments
  61. 7.11 Bristol-Myers Squibb
  62. 7.11.1 Bristol-Myers Squibb Company Information
  63. 7.11.2 Bristol-Myers Squibb Business Overview
  64. 7.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Portfolio
  66. 7.11.5 Bristol-Myers Squibb Recent Developments
  67. 7.12 Aveo Pharmaceuticals
  68. 7.12.1 Aveo Pharmaceuticals Company Information
  69. 7.12.2 Aveo Pharmaceuticals Business Overview
  70. 7.12.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Portfolio
  72. 7.12.5 Aveo Pharmaceuticals Recent Developments
  73. 7.13 Argos Therapeutics
  74. 7.13.1 Argos Therapeutics Company Information
  75. 7.13.2 Argos Therapeutics Business Overview
  76. 7.13.3 Argos Therapeutics Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Argos Therapeutics Kidney Cancer Treatment Drugs Product Portfolio
  78. 7.13.5 Argos Therapeutics Recent Developments
  79. 7.14 Amgen/Allergan
  80. 7.14.1 Amgen/Allergan Company Information
  81. 7.14.2 Amgen/Allergan Business Overview
  82. 7.14.3 Amgen/Allergan Kidney Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Amgen/Allergan Kidney Cancer Treatment Drugs Product Portfolio
  84. 7.14.5 Amgen/Allergan Recent Developments
8 North America
  1. 8.1 North America Kidney Cancer Treatment Drugs Market Size by Type
  2. 8.1.1 North America Kidney Cancer Treatment Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Kidney Cancer Treatment Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Kidney Cancer Treatment Drugs Price by Type (2021-2032)
  5. 8.2 North America Kidney Cancer Treatment Drugs Market Size by Application
  6. 8.2.1 North America Kidney Cancer Treatment Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Kidney Cancer Treatment Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Kidney Cancer Treatment Drugs Price by Application (2021-2032)
  9. 8.3 North America Kidney Cancer Treatment Drugs Market Size by Country
  10. 8.3.1 North America Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Kidney Cancer Treatment Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Kidney Cancer Treatment Drugs Market Size by Type
  2. 9.1.1 Europe Kidney Cancer Treatment Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Kidney Cancer Treatment Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Kidney Cancer Treatment Drugs Price by Type (2021-2032)
  5. 9.2 Europe Kidney Cancer Treatment Drugs Market Size by Application
  6. 9.2.1 Europe Kidney Cancer Treatment Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Kidney Cancer Treatment Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Kidney Cancer Treatment Drugs Price by Application (2021-2032)
  9. 9.3 Europe Kidney Cancer Treatment Drugs Market Size by Country
  10. 9.3.1 Europe Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Kidney Cancer Treatment Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Kidney Cancer Treatment Drugs Market Size by Type
  2. 10.1.1 China Kidney Cancer Treatment Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Kidney Cancer Treatment Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Kidney Cancer Treatment Drugs Price by Type (2021-2032)
  5. 10.2 China Kidney Cancer Treatment Drugs Market Size by Application
  6. 10.2.1 China Kidney Cancer Treatment Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Kidney Cancer Treatment Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Kidney Cancer Treatment Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Kidney Cancer Treatment Drugs Market Size by Type
  2. 11.1.1 Asia Kidney Cancer Treatment Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Kidney Cancer Treatment Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Kidney Cancer Treatment Drugs Price by Type (2021-2032)
  5. 11.2 Asia Kidney Cancer Treatment Drugs Market Size by Application
  6. 11.2.1 Asia Kidney Cancer Treatment Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Kidney Cancer Treatment Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Kidney Cancer Treatment Drugs Price by Application (2021-2032)
  9. 11.3 Asia Kidney Cancer Treatment Drugs Market Size by Country
  10. 11.3.1 Asia Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Kidney Cancer Treatment Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Kidney Cancer Treatment Drugs Market Size by Type
  2. 12.1.1 SAMEA Kidney Cancer Treatment Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Kidney Cancer Treatment Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Kidney Cancer Treatment Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Kidney Cancer Treatment Drugs Market Size by Application
  6. 12.2.1 SAMEA Kidney Cancer Treatment Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Kidney Cancer Treatment Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Kidney Cancer Treatment Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Kidney Cancer Treatment Drugs Market Size by Country
  10. 12.3.1 SAMEA Kidney Cancer Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Kidney Cancer Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Kidney Cancer Treatment Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Kidney Cancer Treatment Drugs Value Chain Analysis
  2. 13.1.1 Kidney Cancer Treatment Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Kidney Cancer Treatment Drugs Production Mode & Process
  6. 13.2 Kidney Cancer Treatment Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Kidney Cancer Treatment Drugs Distributors
  9. 13.2.3 Kidney Cancer Treatment Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst